Esther van den Boom - Sep 6, 2022 Form 4 Insider Report for Tyra Biosciences, Inc. (TYRA)

Role
Chief Financial Officer
Signature
/s/ Ali D. Fawaz, Attorney-in-Fact
Stock symbol
TYRA
Transactions as of
Sep 6, 2022
Transactions value $
$15,346
Form type
4
Date filed
9/8/2022, 05:53 PM
Previous filing
Nov 4, 2021
Next filing
Sep 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TYRA Common Stock Award $15.3K +1.8K +1.52% $8.53 120K Mar 15, 2022 Direct F1
holding TYRA Common Stock 119K Sep 6, 2022 See footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TYRA Stock Option (Right to Buy) Award $0 +105K $0.00 105K Sep 6, 2022 Common Stock 105K $7.14 Direct F3
transaction TYRA Stock Option (Right to Buy) Award $0 +89.1K $0.00 89.1K Sep 6, 2022 Common Stock 89.1K $7.14 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan.
F2 Represents shares held by van den Boom Ventures LLC, of which the spouse of the Reporting Person is the managing member.
F3 1/48th of the shares subject to the option vest monthly following September 6, 2022, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date.
F4 1/36th of the shares subject to the option vest monthly following September 6, 2022, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date.